Photo from wikipedia
https://e-kcj.org In patients with acute coronary syndrome (ACS) treated with percutaneous coronary intervention (PCI), dual antiplatelet therapy (DAPT) is an essential strategy of their management. According to the current guidelines,… Click to show full abstract
https://e-kcj.org In patients with acute coronary syndrome (ACS) treated with percutaneous coronary intervention (PCI), dual antiplatelet therapy (DAPT) is an essential strategy of their management. According to the current guidelines, it is generally recommended to commence DAPT with potent P2Y12 inhibitor (ticagrelor or prasugrel) at the least for 12 months, except in patients with highor very high bleeding risk (HBR).1)
Keywords:
unguided escalation;
strategy;
escalation strategy;
potent p2y12
Journal Title: Korean Circulation Journal
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Korean Circulation Journal
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!